Skip to main content
Figure 3 | Critical Care

Figure 3

From: Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey

Figure 3

Comparison of survival. A Kaplan-Meier curve was calculated to compare the survival between the patients treated with 1,500 IU/day of antithrombin and the patients treated with 3,000 IU/day of antithrombin. The survival started to decrease from day 3 in the AT1500 group and from day 5 in the in the AT3000 group. A significant difference between the groups was recognized on day 28 (P = 0.007, log-rank test).

Back to article page

Critical Care

ISSN: 1364-8535